Home/ Supplements/ Niacin/ Inno Shred GLP-1

Inno Shred GLP-1

product on market Capsule INNOSUPPS Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 60% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

B vitamins and chromium are supported by moderate evidence for assisting energy metabolism and blood glucose regulation. The InnoSlim blend has limited clinical data to support its specific efficacy. Overall, the evidence coverage for this ingredient profile is very low.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Inno Shred GLP-1
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
60%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

15 mg NE (94% DV)
1.1× RDA — within safe limits 196 studies (A:5, B:63)
5 mg (294% DV)
3.8× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
50 mcg (2083% DV)
20.8× RDA — above typical dose 139 studies (A:1, B:44)
300 mcg (857% DV)
8.6× RDA — above typical dose 199 studies (A:1, B:55)
InnoSlim
250 mg
250 mg
Market median: 180.0mg (239 products) 49 studies (A:1, B:19)
Market median: 500.0mg (234 products) 95 studies (A:0, B:35)
Theobromine
100 mg
Paradoxine
40 mg
Alpha Yohimbine
2 mg

Other Ingredients

Hypromellose Microcrystalline Cellulose Magnesium Stearate Silicon Dioxide
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement, take 1 serving (2 capsules) 1 to 2 times daily. For best results, take 30-60 minutes before meals or your workout.

Warnings & Precautions

Do not exceed recommended dosage.

Warning: Check with a qualified healthcare professional before using this product if you are under 18 years of age, pregnant, nursing a baby, if you have any known or suspected medical condition(s) and/or are taking any prescription or OTC medication(s).

Warning: Check with a qualified healthcare professional before using this product if you are under 18 years of age, pregnant, nursing a baby, if you have any known or suspected medical condition(s) and/or are taking any prescription or OTC medication(s). Keep out of reach of children.

Manufactured in a facility and equipment that handles: eggs, wheat, milk, tree nuts, peanuts, soybeans, crustacean shellfish and fish.

Formulation Notes

InnoSlim Paradoxine

Prime your body to lose weight like your favorite celebrities with Inno Shred GLP-1. This cutting-edge formula harnesses the power of Berberine to help curb occasional cravings and support healthy weight loss by promoting your body's production of GLP-1, the "anti-hunger" hormone. Experience a revolutionary approach to fat loss as Inno Shred GLP-1 also helps transform white fat into thermogenic brown adipose tissue, priming your metabolism for supercharged fat-burning while active and at rest with clinically studied ingredients.

Potentiate GLP-1 production Silence food noise Supercharge fat-burning

Silence food noise Supercharge fat-burning Unleash clean energy

Manufactured in the USA with ingredients of international and domestic origin.

Additional Information

Store in a cool, dry place.

Metadata

Product Details

UPC / SKU8 50038 52294 0
DSLD Entry Date2025-04-24
Product TypeOther Combinations
FormCapsule
DSLD ID331213
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.